CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About What We Do Programs and Services CADTH Reimbursement Review Penciclovir

Penciclovir

Last Updated: September 20, 2006

Result type: Reports

Project Number: SR0075-000

Product Line: Reimbursement Review

Generic Name: Penciclovir

Brand Name: Denavir

Manufacturer: Novartis Consumer Health Care Inc.

Therapeutic Area: Herpes labialis (cold sores)

Indications: Herpes labialis (cold sores)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: April 26, 2007

Recommendation Type: Do not list

Penciclovir

Files